In diabetic patients, round the clock tight control of
hyperglycaemia achieved by multiple daily insulin
injections or insulin pumps:
A. Prevents macrovascular disease more
effectively
B. Is recommended in all type 2 diabetes
patients
C. Is associated with higher incidence of hypoglycaemic reactions
D. Both A and C are correct
Show More Ask Question

1 Answer

Answer :

D. Both A and C are correct
Like 0 like
Next Page →

Related

Description : Insulin therapy is required for the following category/ categories of type 2 diabetes mellitus patients: A. Patients with ketoacidosis B. Patients undergoing surgery C. Pregnant diabetic D. All of the above

Answer : D. All of the above

Description : Insulin therapy is required for the following category/ categories of type 2 diabetes mellitus patients: A. Patients with ketoacidosis B. Patients undergoing surgery C. Pregnant diabetic D. All of the above

Answer : D. All of the above

Description : The present status of oral hypoglycaemics in diabetes mellitus is: A. They are the first choice drug in all cases B. They should be prescribed only if the patient refuses insulin injections C. ... I diabetes mellitus D. They are used first in most uncomplicated mild to moderate type 2 diabetics

Answer : D. They are used first in most uncomplicated mild to moderate type 2 diabetics

Description : Which of the following statements is NOT true about diabetes mellitus? A) Type II diabetes is much more common than type I. B) Insulin injections are required in both type I and type II ... -sugar diet. E) Symptoms of diabetes include excessive thirst, frequent urination, and glucose in the urine.

Answer : B) Insulin injections are required in both type I and type II diabetes.

Description : Choose the correct statement about nateglinide: A. It is a long acting oral hypoglycaemic drug B. Taken just before a meal, it limits postprandial hyperglycaemia in type 2 diabetes mellitus C. It lowers ... 1 and type 2 diabetes mellitus D. It acts by opening K+ channels in myocytes and adipocytes

Answer : B. Taken just before a meal, it limits postprandial hyperglycaemia in type 2 diabetes mellitus